Active tuberculosis in inflammatory bowel disease patients: a case–control study

BACKGROUND/AIMS: Anti-tumor necrosis factor (anti-TNF) drugs have been the mainstay therapy for moderate to severe inflammatory bowel disease (IBD) over the past 25 years. Nevertheless, these drugs are associated with serious opportunistic infections like tuberculosis (TB). Brazil is ranked among th...

Descripción completa

Detalles Bibliográficos
Autores principales: Freitas Cardoso de Azevedo, Matheus, Barros, Luísa Leite, Fernandes Justus, Filipe, Oba, Jane, Soares Garcia, Karoline, de Almeida Martins, Camilla, de Sousa Carlos, Alexandre, Arruda Leite, André Zonetti, Miranda Sipahi, Aytan, Queiroz, Natália Sousa Freitas, Omar Mourão Cintra Damião, Adérson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
IBD Barriers Across the Continents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331078/
https://www.ncbi.nlm.nih.gov/pubmed/37435180
http://dx.doi.org/10.1177/17562848231179871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331078/
https://www.ncbi.nlm.nih.gov/pubmed/37435180
http://dx.doi.org/10.1177/17562848231179871

Ejemplares similares